n w    w w w w

baner

Search For New Therapeutic Agents Against Complicated Obesity

By Reprofiling Existing Drugs

 
You are here:   Home What is Reprobesity
large small default
What is Reprobesity PDF Print E-mail

REPROBESITY is a Health Research Project funded by the European Union Seventh Framework Programme (FP7).This project aims to discover novel or improved treatments in the shortest possible timeframe against complicated obesity by reprofiling of existing drugs.

EU Seventh Framework ProgrammeProject Acronym: REPROBESITY

Full title: Search For New Therapeutic Agents Against Complicated Obesity By Reprofiling Existing Drugs

Project Reference: 223713

Start Date: 2008-12-01

Duration: 36 months

Project Cost: 6.95 million euro

Project Funding: 5.4 million euro

End Date: 2011-11-30

Contract Type: Collaborative Project targeted to a special group (such as SMEs)

Research area: HEALTH-2007-1.1-4 SME-driven collaborative research projects for developing tools and technologies for high-throughput research,HEALTH-2007-2.4.3-6 Nutritional signals and the development of new diabetes/obesity therapeutic agents

Project Status: Execution

More information: FP7 CORDIS web page

Last Updated on Tuesday, 07 July 2009 18:37